Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancers

作者: Wen-zhao Zhong , Jian Su , Fang-ping Xu , Hao-ran Zhai , Xu-chao Zhang

DOI: 10.1016/J.LUNGCAN.2015.09.007

关键词:

摘要: Abstract Objectives Most lung adenocarcinomas consist of mixtures histological subtypes harboring different frequencies driver gene mutations. However, little is known about intratumoral heterogeneity(ITH) within histologically heterogeneous primary cancers. Investigating key genes in respective morphological pattern crucial to personalized treatment. Methods Morphologically areas the same surgically resected were extracted from tissues analyze status each growth pattern. Driver genes, epidermal factor receptor (EGFR), KRAS and EML4-ALK, assessed by assays with sensitivities. Results Seventy-nine consecutive eligible patients a (EGFR = 65; KRAS = 10; EML4-ALK = 4) enrolled. For EGFR mutations, ITH occurred 13.3% (8/60) direct sequencing (DS) 1.7% (1/60) amplification refractory mutation system (ARMS) (P = 0.016) among adenocarcinomas, but consistent five adeno-squamous cell carcinomas both methods. mutations detected 20% (2/10) DS, whereas (10/10) high resolution melting. No discrepancies EML4-ALK rearrangements existed according fluorescence situ hybridization. Conclusion Rare ITHs EGFR/KRAS/EML4-ALK alterations methods higher sensitivity. Discrepancies might be due abundance mutant tumor cells detection assays.

参考文章(36)
Jhingook Kim, Myung-Ju Ahn, Yoon-La Choi, Ho Yun Lee, Kyung Soo Lee, Hong Kwan Kim, So-Jung Choi, Joungho Han, Jinseon Lee, Haejoo Choi, Assessment of intratumoral heterogeneity of oncogenic driver mutations in surgically-resected lung adenocarcinoma: implications of percutaneous biopsy-based molecular assay for target-directed therapy Anticancer Research. ,vol. 34, pp. 707- 714 ,(2014)
Johanna Sofia Margareta Mattsson, Juliana Imgenberg-Kreuz, Karolina Edlund, Johan Botling, Patrick Micke, Consistent mutation status within histologically heterogeneous lung cancer lesions Histopathology. ,vol. 61, pp. 744- 748 ,(2012) , 10.1111/J.1365-2559.2012.04245.X
Ji-lin Guan, Wen-zhao Zhong, She-juan An, Jin-ji Yang, Jian Su, Zhi-hong Chen, Hong-hong Yan, Zhi-yong Chen, Zhi-min Huang, Xu-chao Zhang, Qiang Nie, Yi-long Wu, KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy Annals of Surgical Oncology. ,vol. 20, pp. 1381- 1388 ,(2013) , 10.1245/S10434-012-2754-Z
Nicholas C Turner, Jorge S Reis-Filho, Genetic heterogeneity and cancer drug resistance Lancet Oncology. ,vol. 13, ,(2012) , 10.1016/S1470-2045(11)70335-7
Hirofumi Nakano, Hiroshi Soda, Mineyo Takasu, Nanae Tomonaga, Hiroyuki Yamaguchi, Katsumi Nakatomi, Satoru Fujino, Tomayoshi Hayashi, Yoichi Nakamura, Kazuhiro Tsukamoto, Shigeru Kohno, Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule. Lung Cancer. ,vol. 60, pp. 136- 140 ,(2008) , 10.1016/J.LUNGCAN.2007.08.021
L. V. Sequist, B. A. Waltman, D. Dias-Santagata, S. Digumarthy, A. B. Turke, P. Fidias, K. Bergethon, A. T. Shaw, S. Gettinger, A. K. Cosper, S. Akhavanfard, R. S. Heist, J. Temel, J. G. Christensen, J. C. Wain, T. J. Lynch, K. Vernovsky, E. J. Mark, M. Lanuti, A. J. Iafrate, M. Mino-Kenudson, J. A. Engelman, Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002003
Akihiko Yoshizawa, Shinji Sumiyoshi, Makoto Sonobe, Masashi Kobayashi, Masakazu Fujimoto, Fumi Kawakami, Tatsuaki Tsuruyama, William D. Travis, Hiroshi Date, Hironori Haga, Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. Journal of Thoracic Oncology. ,vol. 8, pp. 52- 61 ,(2013) , 10.1097/JTO.0B013E3182769AA8
Sarah Park, Alison J. Holmes-Tisch, Eun Yoon cho, Young Mog Shim, Jinkook Kim, Hyo Song Kim, Jeeyun Lee, Yeon Hee Park, Jin Seok Ahn, Keunchil Park, Pasi A. Jänne, Myung-Ju Ahn, Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer Journal of Thoracic Oncology. ,vol. 4, pp. 809- 815 ,(2009) , 10.1097/JTO.0B013E3181A94AF4
Wen-Zhao Zhong, Yi-Long Wu, Xue-Ning Yang, Ai-Lin Guo, Jian Su, Xu-Chao Zhang, Dong-Lan Luo, Zhen Wang, Hua-Jun Chen, Qing Zhou, Chong-Rui Xu, Gui-Bin Qiao, Ri-Qiang Liao, Jin-Ji Yang, Tony S. Mok, Genetic Evolution of Epidermal Growth Factor Receptor in Adenocarcinoma With a Bronchioloalveolar Carcinoma Component Clinical Lung Cancer. ,vol. 11, pp. 160- 168 ,(2010) , 10.3816/CLC.2010.N.020
Rui Wang, Yunjian Pan, Chenguang Li, Huibiao Zhang, David Garfield, Yuan Li, Ting Ye, Haichuan Hu, Xiaoyang Luo, Hang Li, Yang Zhang, Jie Zhang, Xiaoyan Zhou, Lei Shen, William Pao, Yihua Sun, Haiquan Chen, Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. Journal of Thoracic Oncology. ,vol. 9, pp. 760- 768 ,(2014) , 10.1097/JTO.0B013E3182A406D1